The Northwell Kidney Transplant Program Is Nation’s Best In 2 Survival Metrics

The Northwell Transplant Institute at North Shore University Hospital (NSUH) has been rated the nation’s No. 1 adult kidney transplant program in two key survival metrics, according to new data from the Scientific Registry of Transplant Recipients (SRTR).

NSUH, which completed 195 adult kidney transplants in 2023, is ranked best in the nation for 90-day patient survival. This ranking is based on the hospital’s hazard ratio of 0.35 for the 322 transplants performed between January 1, 2021 and June 30, 2023. NSUH was tops among the 215 hospital programs that perform adult kidney transplants nationally.

In addition, NSUH’s living donor transplant survival rate is best in the U.S., with 100 percent kidney function three years after transplant. Northwell’s overall three-year patient survival hazard ratio for all adult kidney transplants is 0.46, which is among the top 5 percent of U.S. programs and the best in New York State.

“This SRTR report reflects the outstanding care delivered at the Northwell Transplant Institute,” said Nabil Dagher, MD, vice president and director of the Northwell Transplant Institute, “Our entire transplant team is dedicated to helping our patients heal and get back to their best lives.”

The SRTR provides solid organ transplant data in the United States under license from the Health Resources and Services Administration and U.S. Department of Health and Human Services. More than 46,000 organ transplants were performed in 2023, nearly 28,000 of them kidneys, both record highs in the U.S. There were 90,000 people awaiting a kidney transplant during that period.

“Getting a transplant quickly is important, but equally important is making sure the transplant lasts,” said Vinay Nair, DO, medical director of the adult kidney transplant program at the Northwell Transplant Institute. “Having a short time to transplant coupled with some of the best 3-year outcomes in the nation is a testament to the success of our center.”

“A kidney transplant is the gold standard of care for individuals with kidney failure. Transplantation requires a multidisciplinary approach and a dedicated team of transplant professionals,” said Niraj Desai, MD, surgical director of the kidney transplant program at the Northwell Transplant Institute. “We are proud to serve the world’s most diverse population and provide equitable access to care. No one does it better – the evaluation, surgery, postoperative care and long term follow up – than the Northwell Transplant Institute.”

Northwell started performing adult kidney transplants at NSUH in 2007 and established its pediatric kidney transplant program at Cohen Children’s Medical Center in New Hyde Park in 2017. Today, NSUH offers comprehensive solid organ transplantation services for adult heart, kidney, liver and lung.

For more information or to book an appointment, call 516-472-5800 or go to: https://nsuh.northwell.edu/transplant-center/contact-us

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.